Table 1.
Day of presentation vs 12-week follow-up results
| Laboratory test result | Day 1 | Day 3 | Day 6 | 12-week follow-up |
| White blood cell (4,000–11,000 cells/mm3) | 6,400 cells/mm3 | |||
| Hemoglobin (11–15.1 g/dL) | 14.1 g/dL | |||
| Hematocrit (33.1%–44.5%) | 45% | |||
| Platelet (150,000–400,000 cells/mm3) | 226,000 cells/mm3 | |||
| Blood urea nitrogen (6–20 mg/dL) | 13 mg/dL | |||
| Creatinine (0.44–1.03 mg/dL) | 0.58 mg/dL | |||
| Alkaline phosphatase (32–91 U/L) | 246 U/L | 191 U/L | 123 U/L | |
| Aspartate aminotransferase (15–41 U/L) | 46 U/L | 40 U/L | 36 U/L | 19 U/L |
| Alanine aminotransferase (7–52 U/L) | 59 U/L | 51 U/L | 44 U/L | 19 U/L |
| Total bilirubin (0.3–1 mg/dL) | 23.4 mg/dL | 18 U/L | 13 U/L | 0.7 mg/dL |
| Direct bilirubin (0.0–0.3 mg/dL) | 10 mg/dL | 4 U/L | 2 U/L | 0.02 mg/dL |
| GGT (5–45 U/L) | 113 U/L | 74 U/L | 52 U/L | 41 U/L |
| International normalized ratio (0.9–1.1) | 1 | |||
| Lactate dehydrogenase (140-170 U/L) | 162 | |||
| Haptoglobin (55–220 mg/dL) | 50 | |||
| Serum Albumin (3.5–5.1 g/dL) | 4.8 g/dL | |||
| Hepatitis A, B, C, E | Negative | |||
| Cytomegalovirus | Negative | |||
| Parvovirus | Negative | |||
| Herpes simplex virus 1 and 2 | Negative | |||
| HIV 1 and 2 | Negative | |||
| Human papilloma virus | Negative | |||
| Influenza virus | Negative | |||
| Epstein-Barr virus | Negative | |||
| Urine drug screen | Negative | |||
| A1 antitrypsin | Normal | |||
| Ceruloplasmin levels | Normal | |||
| Blood alcohol (<10 mg/dL) | <10 mg/dL | |||
| Acetaminophen level (0–30 μg/mL) | <10 μg/mL | |||
| Salicylate level (0–19.9 mg/dL) | <2.5 mg/dL | |||
| Serum immunoglobulin G (610–1,616 mg/dL) | 900 mg/dL | |||
| Anti-smooth muscle antibody titers | Negative | |||
| Anti-liver-kidney-microsomal antibodies | Negative | |||
| Anti-mitochondrial antibodies | Negative | |||
| Liver kidney microsome type 1 (anti-LKM-1) antibodies | Negative | |||
| Liver kidney microsome type 2 (anti-LKM-1) antibodies | Negative |
GGT, gamma-glutamyl transpeptidase.